123 related articles for article (PubMed ID: 38088856)
1. Functionalized Carbon Nano-Onions as a Smart Drug Delivery System for the Poorly Soluble Drug Carmustine for the Management of Glioblastoma.
Majumder R; Karmakar S; Mishra S; Mallick AB; Das Mukhopadhyay C
ACS Appl Bio Mater; 2024 Jan; 7(1):154-167. PubMed ID: 38088856
[TBL] [Abstract][Full Text] [Related]
2. AN in vitro evaluation of a carmustine-loaded Nano-co-Plex for potential magnetic-targeted intranasal delivery to the brain.
Akilo OD; Choonara YE; Strydom AM; du Toit LC; Kumar P; Modi G; Pillay V
Int J Pharm; 2016 Mar; 500(1-2):196-209. PubMed ID: 26806465
[TBL] [Abstract][Full Text] [Related]
3. Engineering and evaluation of forcespun functionalized carbon nano-onions reinforced poly (ε-caprolactone) composite nanofibers for pH-responsive drug release.
Mamidi N; Zuníga AE; Villela-Castrejón J
Mater Sci Eng C Mater Biol Appl; 2020 Jul; 112():110928. PubMed ID: 32409077
[TBL] [Abstract][Full Text] [Related]
4. Rational design and engineering of carbon nano-onions reinforced natural protein nanocomposite hydrogels for biomedical applications.
Mamidi N; Villela Castrejón J; González-Ortiz A
J Mech Behav Biomed Mater; 2020 Apr; 104():103696. PubMed ID: 32174438
[TBL] [Abstract][Full Text] [Related]
5. Facile functionalization of multilayer fullerenes (carbon nano-onions) by nitrene chemistry and "grafting from" strategy.
Zhou L; Gao C; Zhu D; Xu W; Chen FF; Palkar A; Echegoyen L; Kong ES
Chemistry; 2009; 15(6):1389-96. PubMed ID: 19115308
[TBL] [Abstract][Full Text] [Related]
6. Enhancing pancreatic ductal adenocarcinoma (PDAC) therapy with targeted carbon nano-onion (CNO)-mediated delivery of gemcitabine (GEM)-derived prodrugs.
Bartkowski M; Bincoletto V; Salaroglio IC; Ceccone G; Arenal R; Nervo S; Rolando B; Riganti C; Arpicco S; Giordani S
J Colloid Interface Sci; 2024 Apr; 659():339-354. PubMed ID: 38176243
[TBL] [Abstract][Full Text] [Related]
7. Short-Term Intravenous Administration of Carbon Nano-Onions is Non-Toxic in Female Mice.
Tan YZ; Thomsen LR; Shrestha N; Camisasca A; Giordani S; Rosengren R
Int J Nanomedicine; 2023; 18():3897-3912. PubMed ID: 37483316
[TBL] [Abstract][Full Text] [Related]
8. Brain targeted delivery of carmustine using solid lipid nanoparticles modified with tamoxifen and lactoferrin for antitumor proliferation.
Kuo YC; Cheng SJ
Int J Pharm; 2016 Feb; 499(1-2):10-19. PubMed ID: 26721730
[TBL] [Abstract][Full Text] [Related]
9. Development of Functionalized Carbon Nano-Onions Reinforced Zein Protein Hydrogel Interfaces for Controlled Drug Release.
Mamidi N; González-Ortiz A; Romo IL; Barrera EV
Pharmaceutics; 2019 Nov; 11(12):. PubMed ID: 31757093
[TBL] [Abstract][Full Text] [Related]
10. Multi-Functionalized Carbon Nano-onions as Imaging Probes for Cancer Cells.
Frasconi M; Marotta R; Markey L; Flavin K; Spampinato V; Ceccone G; Echegoyen L; Scanlan EM; Giordani S
Chemistry; 2015 Dec; 21(52):19071-80. PubMed ID: 26577582
[TBL] [Abstract][Full Text] [Related]
11. Covalently Functionalized Carbon Nano-Onions Integrated Gelatin Methacryloyl Nanocomposite Hydrogel Containing γ-Cyclodextrin as Drug Carrier for High-Performance pH-Triggered Drug Release.
Mamidi N; Velasco Delgadillo RM; Barrera EV
Pharmaceuticals (Basel); 2021 Mar; 14(4):. PubMed ID: 33806015
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of bcl-2 and cox-2 Protein Expression after Local Application of a New Carmustine-Loaded Clinoptilolite-Based Delivery System in a Chemically Induced Skin Cancer Model in Mice.
Ghiciuc CM; Strat AL; Ochiuz L; Lupusoru CE; Ignat M; Vasile A; Grigorovici A; Stoleriu I; Solcan C
Molecules; 2017 Nov; 22(11):. PubMed ID: 29156646
[TBL] [Abstract][Full Text] [Related]
13. Synergistic effect of genistein and BCNU on growth inhibition and cytotoxicity of glioblastoma cells.
Khoshyomn S; Nathan D; Manske GC; Osler TM; Penar PL
J Neurooncol; 2002 May; 57(3):193-200. PubMed ID: 12125982
[TBL] [Abstract][Full Text] [Related]
14. 1,3-Bis(2-chloroethyl)-1-nitrosourea-loaded bovine serum albumin nanoparticles with dual magnetic resonance-fluorescence imaging for tracking of chemotherapeutic agents.
Wei KC; Lin FW; Huang CY; Ma CC; Chen JY; Feng LY; Yang HW
Int J Nanomedicine; 2016; 11():4065-75. PubMed ID: 27601895
[TBL] [Abstract][Full Text] [Related]
15. In Vitro and In Vivo Biocompatibility of Boron/Nitrogen Co-Doped Carbon Nano-Onions.
d'Amora M; Camisasca A; Arenal R; Giordani S
Nanomaterials (Basel); 2021 Nov; 11(11):. PubMed ID: 34835781
[TBL] [Abstract][Full Text] [Related]
16. Resorbable polymer microchips releasing BCNU inhibit tumor growth in the rat 9L flank model.
Kim GY; Tyler BM; Tupper MM; Karp JM; Langer RS; Brem H; Cima MJ
J Control Release; 2007 Nov; 123(2):172-8. PubMed ID: 17884232
[TBL] [Abstract][Full Text] [Related]
17. Cationic core-shell nanoparticles with carmustine contained within O⁶-benzylguanine shell for glioma therapy.
Qian L; Zheng J; Wang K; Tang Y; Zhang X; Zhang H; Huang F; Pei Y; Jiang Y
Biomaterials; 2013 Nov; 34(35):8968-78. PubMed ID: 23953782
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of the stability of BCNU using self-emulsifying drug delivery systems (SEDDS) and in vitro antitumor activity of self-emulsified BCNU-loaded PLGA wafer.
Chae GS; Lee JS; Kim SH; Seo KS; Kim MS; Lee HB; Khang G
Int J Pharm; 2005 Sep; 301(1-2):6-14. PubMed ID: 16024190
[TBL] [Abstract][Full Text] [Related]
19. Self-protecting core-shell magnetic nanoparticles for targeted, traceable, long half-life delivery of BCNU to gliomas.
Yang HW; Hua MY; Liu HL; Huang CY; Tsai RY; Lu YJ; Chen JY; Tang HJ; Hsien HY; Chang YS; Yen TC; Chen PY; Wei KC
Biomaterials; 2011 Sep; 32(27):6523-32. PubMed ID: 21645920
[TBL] [Abstract][Full Text] [Related]
20. Combined delivery of BCNU and VEGF siRNA using amphiphilic peptides for glioblastoma.
Yi N; Oh B; Kim HA; Lee M
J Drug Target; 2014 Feb; 22(2):156-64. PubMed ID: 24219243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
